Apoptosis-inducing membrane vesicles - A novel agent with unique properties

被引:48
作者
Jodo, S
Xiao, S
Hohlbaum, A
Strehlow, D
Marshak-Rothstein, A
Ju, ST
机构
[1] Boston Univ, Ctr Arthrit, Sch Med, Dept Med, Boston, MA 02118 USA
[2] Boston Univ, Ctr Arthrit, Sch Med, Dept Microbiol, Boston, MA 02118 USA
关键词
D O I
10.1074/jbc.M107005200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CD95 ligand (FasL) transmembrane protein is found on activated T cells and cells outside the immune system. A well-known turnover process of membrane FasL is mediated by matrix metalloproteinase, which generates soluble FasL (sFasL). Here, we demonstrate that membrane FasL turnover occurs effectively through the release of membrane vesicles. Quantitative analysis indicates that this process is as effective as sFasL release for FasL-3T3 cells but somewhat less effective for FasL-expressing T cells. The apoptosis-inducing membrane vesicles display unique properties not found in FasL-expressing cells and sFasL. Unlike sFasL, vesicle-associated FasL remained bioactive, killing the same panel of targets that are susceptible to FasL-expressing cells. In contrast to FasL-expressing T cells, FasL-mediated killing by vesicles do not involve LFA-1/ICAM interaction and do not depend on de novo protein synthesis. These observations indicate that the release of FasL-bearing vesicles contributes to the turnover of cell-associated FasL, but the impact of the bioactive FasL-expressing vesicles on the function of cell-associated FasL is different from that of sFasL.
引用
收藏
页码:39938 / 39944
页数:7
相关论文
共 54 条
[1]  
Albanese J, 1998, BLOOD, V91, P3862
[2]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[3]   SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS [J].
ANDREWS, BS ;
EISENBERG, RA ;
THEOFILOPOULOS, AN ;
IZUI, S ;
WILSON, CB ;
MCCONAHEY, PJ ;
MURPHY, ED ;
ROTHS, JB ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1198-1215
[4]   Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity [J].
Aoki, K ;
Kurooka, M ;
Chen, JJ ;
Petryniak, J ;
Nabel, EG ;
Nabel, GJ .
NATURE IMMUNOLOGY, 2001, 2 (04) :333-337
[5]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[6]  
Bennett MW, 1998, J IMMUNOL, V160, P5669
[7]   Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells [J].
Bonfoco, E ;
Stuart, PM ;
Brunner, T ;
Lin, T ;
Griffith, TS ;
Gao, Y ;
Nakajima, H ;
Henkart, PA ;
Ferguson, TA ;
Green, DR .
IMMUNITY, 1998, 9 (05) :711-720
[8]   Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells [J].
Bossi, G ;
Griffiths, GM .
NATURE MEDICINE, 1999, 5 (01) :90-96
[9]   CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].
BRUNNER, T ;
MOGIL, RJ ;
LAFACE, D ;
YOO, NJ ;
MAHBOUBI, A ;
ECHEVERRI, F ;
MARTIN, SJ ;
FORCE, WR ;
LYNCH, DH ;
WARE, CF ;
GREEN, DR .
NATURE, 1995, 373 (6513) :441-444
[10]   VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS [J].
BURNS, JC ;
FRIEDMANN, T ;
DRIEVER, W ;
BURRASCANO, M ;
YEE, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8033-8037